{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T10:51:23Z","timestamp":1772275883073,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jhep.2014.06.024","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T03:38:23Z","timestamp":1404272303000},"page":"1143-1150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Development and validation of a polycystic liver disease complaint-specific assessment (POLCA)"],"prefix":"10.1016","volume":"61","author":[{"given":"Frederik","family":"Temmerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Dobbels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thien Anh","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Pirson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragna","family":"Vanslembrouck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Coudyzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Bammens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos","family":"van Pelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Pirenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.06.024_b0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1478-3231.2007.01595.x","article-title":"Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease","volume":"28","author":"Hoevenaren","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.06.024_b0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1478-3231.2010.02247.x","article-title":"Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases","volume":"31","author":"Van Keimpema","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.06.024_b0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2036.2011.04783.x","article-title":"Systematic review: the pathophysiology and management of polycystic liver disease","volume":"34","author":"Temmerman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2014.06.024_b0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/SLA.0b013e3181ad83dc","article-title":"Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation","volume":"250","author":"Schnelldorfer","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2014.06.024_b0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jlts.2001.22178","article-title":"Liver transplantation for polycystic liver disease","volume":"7","author":"Pirenne","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.06.024_b0030","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1432-2277.2011.01360.x","article-title":"Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study","volume":"24","author":"van Keimpema","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2014.06.024_b0035","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.024_b0040","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2014.06.024_b0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2036.2011.04923.x","article-title":"The long-term outcome of patients with polycystic liver disease treated with lanreotide","volume":"35","author":"Chrispijn","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2014.06.024_b0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.gastro.2013.04.055","article-title":"Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data","volume":"145","author":"Gevers","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.024_b0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/apt.12384","article-title":"Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data","volume":"38","author":"Temmerman","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2014.06.024_b0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2013.03.004","article-title":"Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trial","volume":"59","author":"Chrispijn","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.024_b0065","unstructured":"US Department of Health and Human Services Food and Drug Administration. Guidance for industry. Patient reported outcome measures: tools in medical product development to support labeling claims, www.fda.gov\/downloads\/Drugs\/Guidances\/UCM193282.pdf."},{"key":"10.1016\/j.jhep.2014.06.024_b0070","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.2146\/ajhp070364","article-title":"Validity and reliability of measurement instrument used in research","volume":"65","author":"Kimberlin","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jhep.2014.06.024_b0075","series-title":"Behavioral science and nursing theory","first-page":"189","article-title":"Laboratory and field experimentation: development of a theory of self-regulation","author":"Leventhal","year":"1983"},{"key":"10.1016\/j.jhep.2014.06.024_b0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0749-2081(87)80014-1","article-title":"Symptom distress\u2014the concept: past and present","volume":"3","author":"Rhodes","year":"1987","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.jhep.2014.06.024_b0085","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.3748\/wjg.v13.i38.5052","article-title":"Surgical management of polycystic liver disease","volume":"13","author":"Russell","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.06.024_b0090","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/S0041-1345(97)00696-9","article-title":"Liver transplantation in patients with polycystic liver disease","volume":"29","author":"Lang","year":"1997","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2014.06.024_b0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hep.510280218","article-title":"Liver transplantation for adult polycystic liver disease","volume":"28","author":"Swenson","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.024_b0100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1432-2277.2002.tb00111.x","article-title":"Living related liver transplantation for polycystic liver disease","volume":"15","author":"Koyama","year":"2002","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2014.06.024_b0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1432-2277.2005.00061.x","article-title":"Liver transplantation with preservation of the inferior vena cava in case of symptomatic adult polycystic","volume":"18","author":"Lerut","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2014.06.024_b0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/01.tp.0000231712.75645.7a","article-title":"Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome","volume":"82","author":"Ueno","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2014.06.024_b0115","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/lt.20780","article-title":"Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation","volume":"12","author":"Kirchner","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.06.024_b0120","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/lt.20796","article-title":"Quality of life and liver transplantation in patients with polycystic liver disease","volume":"12","author":"Dan","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.06.024_b0125","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/lt.21423","article-title":"Living donor liver transplantation in polycystic liver disease","volume":"14","author":"Mekeel","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.06.024_b0130","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/gut.2008.155721","article-title":"Somatostatin analogues reduce liver volume in polycystic liver disease","volume":"57","author":"Van Keimpema","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.06.024_b0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2215\/CJN.05380709","article-title":"Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide","volume":"5","author":"Caroli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2014.06.024_b0140","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1186\/1477-7525-10-80","article-title":"The importance of rating scales in measuring patient-reported outcomes","volume":"10","author":"Khadka","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jhep.2014.06.024_b0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00000658-199703000-00008","article-title":"Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?","volume":"225","author":"Gigot","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2014.06.024_b0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2003.50006","article-title":"Clinical profile of autosomal dominant polycystic liver disease","volume":"37","author":"Qian","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.024_b0155","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 health survey update","volume":"11","author":"Ware","year":"2000","journal-title":"Spine"},{"key":"10.1016\/j.jhep.2014.06.024_b0160","series-title":"How to score version 2 of the SF-36 health survey","author":"Ware","year":"2000"},{"key":"10.1016\/j.jhep.2014.06.024_b0165","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.1840210515","article-title":"Calculation of child and adult standard liver volume for liver transplantation","volume":"21","author":"Urata","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.024_b0170","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.1177\/000313481307900308","article-title":"Fenestration treatment for polycystic liver disease improved quality of life","volume":"79","author":"Yilmaz","year":"2013","journal-title":"Am Surg"},{"key":"10.1016\/j.jhep.2014.06.024_b0175","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/lt.20974","article-title":"Model for end-stage liver disease (MELD) exception for polycystic liver disease","volume":"12","author":"Arrazola","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.06.024_b0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cgh.2011.08.028","article-title":"Muscle wasting is associated with mortality in patients with cirrhosis","volume":"10","author":"Montano-Loza","year":"2012","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814004541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814004541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T08:35:56Z","timestamp":1649579756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814004541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0168827814004541"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.06.024","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a polycystic liver disease complaint-specific assessment (POLCA)","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}